Results 241 to 250 of about 2,123,606 (402)

Targeted Nanoparticles for Molecular Imaging and Therapy [PDF]

, 2006
Shelton D. Caruthers, Samuel A. Wickline, Gregory M. Lanza   +2 more
openalex   +1 more source

TOMM20 as a driver of cancer aggressiveness via oxidative phosphorylation, maintenance of a reduced state, and resistance to apoptosis

Molecular Oncology, EarlyView.
TOMM20 increases cancer aggressiveness by maintaining a reduced state with increased NADH and NADPH levels, oxidative phosphorylation (OXPHOS), and apoptosis resistance while reducing reactive oxygen species (ROS) levels. Conversely, CRISPR‐Cas9 knockdown of TOMM20 alters these cancer‐aggressive traits.
Ranakul Islam, Megan E. Roche, Zhao Lin, Diana Whitaker‐Menezes, Victor Diaz‐Barros, Eurico Serrano, Maria Paula Martinez Cantarin, Nancy J. Philp, Atrayee Basu Mallick, Ubaldo Martinez‐Outschoorn   +9 more
wiley   +1 more source

Effectiveness and tolerability of camrelizumab combined with molecular targeted therapy for patients with unresectable or advanced HCC. [PDF]

Cancer Immunol Immunother, 2023
Li T, Guo J, Liu Y, Du Z, Guo Z, Fan Y, Cheng L, Zhang Y, Gao X, Zhao Y, He X, Wu W, Gao N, Wu Y, Li J, Zhang Y, Kang W, Cai Z, Wang W, Li X, Zan Y, Nguyen MH, Ji F.   +22 more
europepmc   +1 more source

Radiopharmaceuticals: From Molecular Imaging to Targeted Radionuclide Therapy

, 2004
P. August Schubiger, Jürgen Grünberg, Simon M. Ametamey, Michael Honer, Elisa García‐Garayoa, Peter Bläuenstein, Robert Waibel, Ilse Novak‐Hofer, Roger Schibli   +8 more
openalex   +2 more sources

Increasing Molecular Mass Allows Better Tumor Targeting and Retention of Cancer Therapy [PDF]

, 2006

openalex   +1 more source

Plasma lipidomic and metabolomic profiles in high‐grade glioma patients before and after 72‐h presurgery water‐only fasting

Molecular Oncology, EarlyView.
Presurgery 72‐h fasting in GB patients leads to adaptations of plasma lipids and polar metabolites. Fasting reduces lysophosphatidylcholines and increases free fatty acids, shifts triglycerides toward long‐chain TGs and increases branched‐chain amino acids, alpha aminobutyric acid, and uric acid.
Iris Divé, Lisa Hahnefeld, Katharina J. Wenger, Donat Kögel, Joachim Steinbach, Gerd Geisslinger, Michael W. Ronellenfitsch, Irmgard Tegeder   +7 more
wiley   +1 more source

Delayed pharyngocutaneous fistula caused by molecular targeted therapy: a case report. [PDF]

J Med Case Rep, 2022
Matsuo M, Hashimoto K, Jiromaru R, Nakagawa T.   +3 more
europepmc   +1 more source

Review: Side Effects of Approved Molecular Targeted Therapies in Solid Cancers [PDF]

, 2007
C. Widakowich, Gilberto de Castro, Evandro de Azambuja, Phuong Dinh, Ahmad Awada   +4 more
openalex   +1 more source

Transcriptome‐wide analysis of circRNA and RBP profiles and their molecular relevance for GBM

Molecular Oncology, EarlyView.
CircRNAs are differentially expressed in glioblastoma primary tumors and might serve as therapeutic targets and diagnostic markers. The investigation of circRNA and RNA‐binding proteins (RBPs) interactions shows that distinct RBPs play a role in circRNA biogenesis and function.
Julia Latowska‐Łysiak, Żaneta Zarębska, Marcin P. Sajek, Adriana Grabowska, Alessia Buratin, Paweł Głodowicz, Julia O. Misiorek, Konrad Kuczyński, Stefania Bortoluzzi, Marek Żywicki, Jan G. Kosiński, Agnieszka Rybak‐Wolf, Rafał Piestrzeniewicz, Anna M. Barciszewska, Katarzyna Rolle   +14 more
wiley   +1 more source

Molecular-Targeted Therapy for Tumor-Agnostic Mutations in Acute Myeloid Leukemia. [PDF]

Biomedicines, 2022
Arai H, Minami Y, Chi S, Utsu Y, Masuda S, Aotsuka N.   +5 more
europepmc   +1 more source